{
    "nctId": "NCT05417048",
    "briefTitle": "Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast Cancer",
    "officialTitle": "miRNAs of Circulating Glycosylated Extracellular Vesicles as Biomarkers for Early Diagnosis of Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 420,
    "primaryOutcomeMeasure": "The diagnostic performance of the blood assay for differentiating benign and malignant breast disease using glycosylated extracellular vesicles analysis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients\u226518 years old\uff1b\n2. Histologically confirmed breast cancer patients\uff0cBenign breast disease \uff08ig. breast fibroma, intraductal papilloma,mammary hyperplasia, breast cyst\uff09or No breast lesions detected by clinical examination/mammography/ultrasound/breast magnetic resonance imaging (MRI)\n3. Previous not received preoperative radiotherapy, chemotherapy, endocrine therapy, immunotherapy, or other anticancer treatments.\n4. Subjects signed informed consent\uff1b\n\nExclusion Criteria:\n\n1. A history of prior or concomitant malignancies;\n2. advanced stage breast cancer (stage IV)\uff1b\n3. Patients were accompanied by severe organic diseases such as heart and cerebral disease, and liver and kidney disease.\uff1b\n4. Pregnant or lactating women \uff1b\n5. Suspected or confirmed lesion was surgically removed\uff1b\n6. Patients with incomplete clinical data\uff1b\n7. Patients with poor compliance\uff1b\n8. Patients with severe mental illness\uff1b\n9. Patients had received blood transfusions during one month\u4e00\uff1b",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}